Evidence map›Paper›PMID 19130244›Full record

ArticleBiomedical microdevices2009

Integrated microfluidic devices for combinatorial cell-based assays.

Zeta Tak For Yu, Ken-ichiro Kamei, Hiroko Takahashi, Chengyi Jenny Shu, Xiaopu Wang, George Wenfu He, Robert Silverman, Caius G Radu, Owen N Witte, Ki-Bum Lee and 1 more

Open access · greenAbstract read
In one paragraph

Article in Biomedical microdevices, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Transfection in perfused microfluidic cell culture devices: A case study.Process biochemistry (Barking, London, England) · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Zeta Tak For YuDepartment of Mechanical and Aerospace Engineering, University of California, Los Angeles, CA 90095, USA.
Ken-ichiro Kamei
Hiroko Takahashi
Chengyi Jenny Shu
Xiaopu Wang
George Wenfu He
Robert Silverman
Caius G Radu
Owen N Witte
Ki-Bum Lee
Hsian-Rong Tseng
University of California, Los Angeles · USHoward Hughes Medical Institute · USInstitute for Molecular Medicine · USRutgers, The State University of New Jersey · US

Funding

QUANTITATIVE IMAGE ANALYSIS SPECIALIZED RESOURCE COREU54CA119347 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI MISCHEL, PAUL S · 2005 to 2009
$17.8M
RESEARCH TRAINING IN PHARMACOLOGICAL SCIENCEST32GM008652 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HERSCHMAN, HARVEY R. · 1998 to 2005
$1.1M
Howard Hughes Medical InstituteNCI NIH HHS CA08630NCI NIH HHS T32 CM008652NCI NIH HHS U54 CA119347NIGMS NIH HHS T32 GM008652
6 · The paper itself

Abstract

The development of miniaturized cell culture platforms for performing parallel cultures and combinatorial assays is important in cell biology from the single-cell level to the system level. In this paper we developed an integrated microfluidic cell-culture platform, Cell-microChip (Cell-microChip), for parallel analyses of the effects of microenvironmental cues (i.e., culture scaffolds) on different mammalian cells and their cellular responses to external stimuli. As a model study, we demonstrated the ability of culturing and assaying several mammalian cells, such as NIH 3T3 fibroblast, B16 melanoma and HeLa cell lines, in a parallel way. For functional assays, first we tested drug-induced apoptotic responses from different cell lines. As a second functional assay, we performed "on-chip" transfection of a reporter gene encoding an enhanced green fluorescent protein (EGFP) followed by live-cell imaging of transcriptional activation of cyclooxygenase 2 (Cox-2) expression. Collectively, our Cell-microChip approach demonstrated the capability to carry out parallel operations and the potential to further integrate advanced functions and applications in the broader space of combinatorial chemistry and biology.

Indexed as

AnimalsAnnexin A5Antibiotics, AntineoplasticApoptosisBioreactorsCell Culture TechniquesCell ProliferationCell SurvivalCyclooxygenase 2DactinomycinDose-Response Relationship, DrugEnzyme InhibitorsEquipment DesignFibroblastsFibronectinsGenes, ReporterAnnexin A5Antibiotics, AntineoplasticCyclooxygenase 2Dactinomycinenhanced green fluorescent proteinEnzyme InhibitorsFibronectinsGreen Fluorescent ProteinsStaurosporine

Identifiers

PMID19130244
PMCPMC2893875
OpenAlexW2015277664

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.